Anirolac
Anirolac (RS37326) is a nonsteroidal anti-inflammatory agent with analgesic activity. Anirolac showed analgesic efficacy comparable to that of naproxen in suppressing moderate or severe postpartum uterine pain. Anirolac induced significantly higher analgesia scores than placebo within 6 hours, especially at the 100 mg dose. Anirolac effectively relieved pain and showed a stronger analgesic effect than placebo in every assessment[1].
Product Specifications
CAS Number
66635-85-6
Product Name Alternative
RS37326
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Endogenous Metabolite
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/anirolac.html
Purity
97.0
Smiles
O=C(C1C2=CC=C(N2CC1)C(C3=CC=C(C=C3)OC)=O)O
Molecular Formula
C16H15NO4
Molecular Weight
285.29
Precautions
H302, H315, H319, H335
References & Citations
[1]Anirolac vs. naproxen for postpartum uterine pain
Shipping Conditions
Room Temperature
Storage Conditions
Store at room temperature 3 years
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Colloidal Gold Conjugated Sophora japonica (Pagoda Tree) -SJA-, 1mL 10nm
MART-1 / Melan-A (A103), CF405S conjugate, 0.1mg/mL
IFluor® 568 goat anti-rabbit IgG (H+L) *Cross Adsorbed*
